SCHEMBL30003514

SCHEMBL30003514

Cc1cc(C(=O)CCc2nc(-c3ccc(Cl)cc3O)oc2C(C)C)ccc1OCCO

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 5/20 0.48
PPARD Q03181 5/20 0.48
PPARA Q07869 5/20 0.48
S1PR3 Q99500 2/20 0.39
GAA P10253 1/20 0.37
KDM4E B2RXH2 3/20 0.36
TP53 P04637 1/20 0.36
ALOX15 P16050 1/20 0.36
ALDH1A1 P00352 2/20 0.36
THRA P10827 1/20 0.36
THRB P10828 1/20 0.36
MAPT P10636 3/20 0.35
MEN1 O00255 3/20 0.35
KMT2A Q03164 3/20 0.35
RAB9A P51151 2/20 0.35
LMNA P02545 1/20 0.35
KCNH2 Q12809 1/20 0.35
MAPK1 P28482 1/20 0.35
CETP P11597 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24658330 1.00 PPARG (0.48) PPARGPPARDPPARAS1PR3GAA
SCHEMBL24658335 0.93 PPARA (0.55) PPARGPPARDPPARAS1PR3GAA
SCHEMBL30003540 0.93 PPARA (0.55) PPARGPPARDPPARAS1PR3GAA
SCHEMBL12732399 0.92 PPARG (0.49) PPARGPPARDPPARAS1PR3GAA
SCHEMBL2467524 0.92 PPARG (0.46) PPARGPPARDPPARAGAAKDM4E
SCHEMBL2460899 0.90 PPARD (0.59) PPARGPPARDPPARAKDM4EMAPT
SCHEMBL20815372 0.88 PPARD (0.47) PPARGPPARDPPARAS1PR3KDM4E
SCHEMBL4755260 0.88 PPARG (0.49) PPARGPPARDPPARAKDM4EALDH1A1
SCHEMBL24742416 0.87 PPARA (0.50) PPARGPPARDPPARATP53THRA
SCHEMBL30004652 0.87 PPARA (0.50) PPARGPPARDPPARATP53THRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250333379-A1 Compounds Useful for Treating Liver Diseases ABIONYX PHARMA SA (FR) 2025-10-30 US disclosed
US-12297168-B2 Compounds useful for treating liver diseases ABIONYX PHARMA SA (FR) 2025-05-13 US disclosed
US-20240199575-A1 COMPOUNDS USEFUL FOR TREATING LIVER DISEASES ABIONYX PHARMA SA (FR) 2024-06-20 US disclosed
US-20230278952-A1 Compounds Useful for Treating Liver Diseases ABIONYX PHARMA SA (FR) 2023-09-07 US disclosed
US-11634387-B2 Compounds useful for treating liver diseases ABIONYX PHARMA SA (FR) 2023-04-25 US disclosed
US-20220363632-A1 Compounds Useful for Treating Liver Diseases ABIONYX PHARMA SA (FR) 2022-11-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230278952-A1 Compounds Useful for Treating Liver Diseases SLC10A1, FABP1, CPT1A PPARG 71/4885PPARD 332/4885PPARA 94/4885
US-20240199575-A1 COMPOUNDS USEFUL FOR TREATING LIVER DISEASES SLC10A1, FABP1, CPT1A PPARG 71/4885PPARD 332/4885PPARA 94/4885
US-11634387-B2 Compounds useful for treating liver diseases SLC10A1, FABP1, CPT1A PPARG 71/4885PPARD 332/4885PPARA 94/4885
US-20250333379-A1 Compounds Useful for Treating Liver Diseases SLC10A1, FABP1, CPT1A PPARG 71/4885PPARD 332/4885PPARA 94/4885
US-12297168-B2 Compounds useful for treating liver diseases SLC10A1, FABP1, CPT1A PPARG 71/4885PPARD 332/4885PPARA 94/4885
US-20220363632-A1 Compounds Useful for Treating Liver Diseases SLC10A1, FABP1, CPT1A PPARG 71/4885PPARD 332/4885PPARA 94/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.